Evidence map›Paper›PMID 24332981›Full record

ArticleExperimental cell research2014

Alpha-2 Heremans Schmid Glycoprotein (AHSG) modulates signaling pathways in head and neck squamous cell carcinoma cell line SQ20B.

Pamela D Thompson, Amos Sakwe, Rainelli Koumangoye, Wendell G Yarbrough, Josiah Ochieng, Dana R Marshall

Abstract read
In one paragraph

Article in Experimental cell research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. The Role of Fetuin-A in Tumor Cell Growth, Prognosis, and Dissemination.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Impact of Fetuin-A (AHSG) on Tumor Progression and Type 2 Diabetes.International journal of molecular sciences · 2018
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Pamela D ThompsonDepartment of Biochemistry and Cancer Biology, Meharry Medical College, Nashville, TN 37208, USA.
Amos SakweDepartment of Biochemistry and Cancer Biology, Meharry Medical College, Nashville, TN 37208, USA.
Rainelli KoumangoyeDivision of Surgical Oncology and Endocrine Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Wendell G YarbroughDivision of Otolaryngology, Departments of Surgery and Pathology and Yale Cancer Center, Yale University, New Haven, CT 06520, USA.
Josiah OchiengDepartment of Biochemistry and Cancer Biology, Meharry Medical College, Nashville, TN 37208, USA.
Dana R MarshallDepartment of Pathology, Anatomy and Cell Biology, Meharry Medical College, Nashville, TN 37208, USA. Electronic address: dmarshall@mmc.edu.
Meharry Medical College · USVanderbilt University Medical Center · USYale University · US

Funding

Technologies and Resources CoreU54MD007593 · NIMHD · MEHARRY MEDICAL COLLEGE · PI ADUNYAH, SAMUEL EVANS · 2012 to 2018
$24.7M
ROLES OF STATS AND SRC KINASES IN GROWTH CONTROL BY IL17U54CA091408 · NCI · MEHARRY MEDICAL COLLEGE · PI ADUNYAH, SAMUEL EVANS · 2001 to 2010
$20.2M
TrainingU54CA163072 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Karen Marie Winkfield · 2011 to 2026
$20.1M
Translational Pathology CoreU54CA163069 · NCI · MEHARRY MEDICAL COLLEGE · PI BALLARD, BILLY RAY · 2011 to 2025
$18.8M
TECHNOLOGIES AND RESOURCES FOR CORE LABORATORIESU54RR026140 · NCRR · MEHARRY MEDICAL COLLEGE · PI GOODWIN, JEFFREY SHAWN · 2009 to 2011
$12.9M
TRAININGU54CA163066 · NCI · TENNESSEE STATE UNIVERSITY · PI MARGARET M WHALEN · 2011 to 2026
$12.8M
Meharry RCMI Program in Women's Health ResearchG12MD007586 · NIMHD · MEHARRY MEDICAL COLLEGE · PI HILDRETH, JAMES E · 2012 to 2016
$7.8M
Minority Institution Research Training ProgramT32HL007735 · NHLBI · MEHARRY MEDICAL COLLEGE · PI ADUNYAH, SAMUEL EVANS · 1992 to 2014
$2.9M
Role of Fetuin-A in Tumor Cell GrowthSC1CA134018 · NCI · MEHARRY MEDICAL COLLEGE · PI OCHIENG, JOSIAH · 2007 to 2012
$1.7M
NCI NIH HHS SC1 CA134018NCI NIH HHS SC1CA134018-01NCI NIH HHS U54 CA091408NCI NIH HHS U54CA091408NCI NIH HHS U54 CA163066NCI NIH HHS U54 CA163069NCI NIH HHS U54 CA163072NCRR NIH HHS S10RR0254970NCRR NIH HHS U54 RR026140NHLBI NIH HHS 5T32HL007735-15NHLBI NIH HHS T32 HL007735NIMHD NIH HHS G12 MD007586NIMHD NIH HHS G12MD007586NIMHD NIH HHS U54 MD007593NIMHD NIH HHS U54MD007593
6 · The paper itself

Abstract

This study was performed to identify the potential role of Alpha-2 Heremans Schmid Glycoprotein (AHSG) in Head and Neck Squamous Cell Carcinoma (HNSCC) tumorigenesis using an HNSCC cell line model. HNSCC cell lines are unique among cancer cell lines, in that they produce endogenous AHSG and do not rely, solely, on AHSG derived from serum. To produce our model, we performed a stable transfection to down-regulate AHSG in the HNSCC cell line SQ20B, resulting in three SQ20B sublines, AH50 with 50% AHSG production, AH20 with 20% AHSG production and EV which is the empty vector control expressing wild-type levels of AHSG. Utilizing these sublines, we examined the effect of AHSG depletion on cellular adhesion, proliferation, migration and invasion in a serum-free environment. We demonstrated that sublines EV and AH50 adhered to plastic and laminin significantly faster than the AH20 cell line, supporting the previously reported role of exogenous AHSG in cell adhesion. As for proliferative potential, EV had the greatest amount of proliferation with AH50 proliferation significantly diminished. AH20 cells did not proliferate at all. Depletion of AHSG also diminished cellular migration and invasion. TGF-β was examined to determine whether levels of the TGF-β binding AHSG influenced the effect of TGF-β on cell signaling and proliferation. Whereas higher levels of AHSG blunted TGF-β influenced SMAD and ERK signaling, it did not clearly affect proliferation, suggesting that AHSG influences on adhesion, proliferation, invasion and migration are primarily due to its role in adhesion and cell spreading. The previously reported role of AHSG in potentiating metastasis via protecting MMP-9 from autolysis was also supported in this cell line based model system of endogenous AHSG production in HNSCC. Together, these data show that endogenously produced AHSG in an HNSCC cell line, promotes in vitro cellular properties identified as having a role in tumorigenesis.

Indexed as

alpha-2-HS-GlycoproteinBinding, CompetitiveCarcinogenesisCarcinoma, Squamous CellCell AdhesionCell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticHead and Neck NeoplasmsHumansMatrix Metalloproteinase 9RNA, Small InterferingSignal TransductionSquamous Cell Carcinoma of Head and NeckTransforming Growth Factor beta1AHSG protein, humanalpha-2-HS-GlycoproteinMatrix Metalloproteinase 9MMP9 protein, humanRNA, Small InterferingTransforming Growth Factor beta1AdhesionAHSGHNSCCInvasionMetastasisMigrationMMP-9TGF-β

Identifiers

PMID24332981
PMCPMC4096485
OpenAlexW2034228519

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.